Monopar Therapeutics Inc (MNPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 6,155 | 4,093 | 3,234 | 3,222 | 11,075 |
| Operating Income | -6,155 | -4,093 | -3,234 | -3,222 | -11,075 |
| Other Income | 954 | 656 | 781 | 597 | 149 |
| Pre-tax Income | -5,201 | -3,438 | -2,454 | -2,625 | -10,926 |
| Net Income Continuous | -5,201 | -3,438 | -2,454 | -2,625 | -10,926 |
| Net Income | $-5,201 | $-3,438 | $-2,454 | $-2,625 | $-10,926 |
| EPS Basic Total Ops | -0.64 | -0.48 | -0.35 | -0.38 | -2.74 |
| EPS Basic Continuous Ops | -0.64 | -0.48 | -0.35 | -0.38 | -2.74 |
| EPS Diluted Total Ops | -0.64 | -0.48 | -0.35 | -0.38 | -2.74 |
| EPS Diluted Continuous Ops | -0.64 | -0.48 | -0.35 | -0.38 | -2.74 |
| EPS Diluted Before Non-Recurring Items | -0.61 | -0.48 | -0.35 | -0.38 | -2.23 |
| EBITDA(a) | $-6,155 | $-4,093 | $-3,234 | $-3,222 | $-11,075 |